Evidence map›Paper›PMID 34993542›Full record

ArticleInternational journal of epidemiology2022

Glycated haemoglobin (HbA1c) in mid-pregnancy and perinatal outcomes.

Ellen Ø Carlsen, Quaker Harmon, Maria C Magnus, Helle M Meltzer, Iris Erlund, Lars C Stene, Siri E Håberg, Allen J Wilcox

Abstract read
In one paragraph

Article in International journal of epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ellen Ø CarlsenCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Quaker HarmonEpidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, USA.ORCID 0000-0002-5866-848X
Maria C MagnusCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Helle M MeltzerDivision of Climate and Environment, Environment and Health, Norwegian Institute of Public Health, Oslo, Norway.
Iris ErlundDepartment of Government Services (Biomarkers Team), Finnish Institute for Health and Welfare, Helsinki, Finland.
Lars C SteneDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.
Siri E HåbergCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-2199-5225
Allen J WilcoxEpidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, USA.

Funding

Medical Research Council MC_UU_00011/3Medical Research Council MC_UU_00011/6
6 · The paper itself

Abstract

backgroundMaternal diabetes is a well-known risk factor for pregnancy complications. Possible links between long-term maternal blood sugar in the normal range and pregnancy complications are less well described.

methodsWe assayed glycated haemoglobin (HbA1c) in blood samples collected around the 18th week of pregnancy for 2937 singleton pregnancies in the Norwegian Mother, Father and Child Cohort Study (2000-09). Perinatal outcomes (gestational length, birthweight, birth length and head circumference, large-for-gestational age, small-for-gestational age, congenital malformations, preterm delivery and preeclampsia) were obtained from medical records. We tested associations using linear and log-binomial regression, adjusting for maternal age, body mass index (BMI) and smoking.

resultsSize at birth increased modestly but linearly with HbA1c. Birthweight rose 0.10 standard deviations [95% confidence interval (CI): 0.03, 0.16], for each 5-mmol/mol unit increase in HbA1c, corresponding to about 40 g at 40 weeks of gestation. Large-for-gestational age rose 23% (95% CI: 1%, 50%) per five-unit increase. Other pregnancy complications increased in non-linear fashion, with strongest associations within the top quartile of HbA1c (>35 mmol/mol or >5.4%). Per unit HbA1c within the top quartile, preterm delivery increased by 14% (95% CI: 1%, 31%), preeclampsia increased by 20% (95% CI: 5%, 37%) and gestational duration decreased by 0.7 days (95% CI: -1.0, -0.3).

conclusionsAmong women with no recorded diabetes, higher HbA1c levels at 18 gestational weeks were associated with important perinatal outcomes independent of mother's age, smoking or BMI.

Indexed as

Diabetes, GestationalPre-EclampsiaPremature BirthBirth WeightCohort StudiesFemaleGlycated HemoglobinHumansInfant, NewbornNorwayPregnancyPregnancy OutcomeGlycated HemoglobinBirthweightdiabetesglucoseHbA1cMoBapreeclampsiapregnancypregnancy complicationspreterm

Identifiers

PMID34993542
PMCPMC9189945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.